封面
市场调查报告书
商品编码
1890958

血脂检查市场:依检测类型、产品类型、应用、配方、最终用户和地区划分

Lipid Panel Test Market, By Test Type, By Product Type, By Application, By Prescription Mode, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2025 年,血脂检查市场规模将达到 118.2 亿美元,到 2032 年将达到 201.3 亿美元,2025 年至 2032 年的复合年增长率为 7.9%。

报告内容 报告详情
基准年: 2024 2025年市场规模: 118.2亿美元
历史数据时期: 2020年至2024年 预测期: 2025年至2032年
预测期(2025-2032年)复合年增长率: 7.90% 2032 年的预测值: 201.3亿美元

全球血脂检查市场是临床诊断行业的重要组成部分,包括测量各种胆固醇和三酸甘油酯水平以评估心血管疾病风险的综合血液检测。血脂检查(也称为血脂谱或血脂图)评估患者血液样本中的总胆固醇、低密度脂蛋白胆固醇 (LDL)、高密度脂蛋白胆固醇 (HDL) 和三酸甘油酯。

这些诊断评估是基本的筛检工具,可帮助医疗保健提供者识别有动脉粥状硬化、冠状动脉疾病和其他心血管併发症的个体。市面上的检测方法多种多样,包括酵素法、均相法和先进的自动化分析仪,并已应用于医院、诊断检查室和照护现场机构。

随着文明病的增加、人口老化以及人们对预防性医疗保健措施意识的提高,全球对血脂检查的需求持续增长。高通量分析仪、携带式检测设备和数位健康平台等技术创新的融合,显着提高了血脂检测的可及性和效率,使其在世界各地的各种医疗机构中都能为医护人员和患者带来更多便利。

市场动态

全球血脂检查市场成长的主要驱动力是心血管疾病、糖尿病和肥胖症的日益流行,这显着增加了对定期血脂监测和筛检的需求。人口老化,尤其是在已开发国家,也对市场成长做出了重要贡献,因为老年人需要频繁进行心血管风险评估和血脂监测。

诊断设备的科技进步,特别是高通量自动化分析仪、就地检验设备和携带式血脂检测解决方案的开发,提高了检测的准确性、效率和可及性,从而推动了市场扩张。政府为促进预防性医疗保健措施、心血管疾病筛检计画和健康意识宣传活动采取的倡议,也进一步刺激了市场需求。

然而,先进诊断设备和检测程序的高成本是限制因素之一,这可能会限制资源匮乏的医疗机构和发展中地区的医疗服务取得。诊断设备核准、品管标准和检查室认证的严格监管要求构成市场准入壁垒,并增加了製造商的合规成本。此外,某些地区医疗基础设施不足、熟练实验室技术人员短缺以及报销政策不完善也阻碍了市场成长。

然而,新兴市场蕴藏着巨大的机会,这得益于医疗基础设施的不断改善、医疗支出的成长以及人们对心血管健康的日益意识提升。人工智慧、机器学习演算法和远端医疗平台的融合,为开发创新血脂检测解决方案和远端监测功能提供了契机。居家医疗和自我管理设备的普及,为直接面向消费者的血脂检测产品创造了市场机会,而诊断公司与医疗服务提供者之间的合作,则有望推动全球市场渗透和服务拓展。

本次调查的主要特点

  • 本报告对全球血脂检查市场进行了详细分析,以 2024 年为基准年,给出了预测期(2025-2032 年)内的市场规模(十亿美元)和復合年增长率(%)。
  • 我们将重点介绍各个细分市场的潜在商机,并说明该市场具有吸引力的投资提案矩阵。
  • 该研究还提供了有关市场驱动因素、阻碍因素、机会、新产品发布或核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
  • 本研究根据以下参数介绍了全球血脂检查市场主要企业的概况:公司概况、产品系列、主要亮点、财务表现和策略。
  • 本报告的研究结果将使负责人和企业经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 这份全球血脂检查市场报告的目标受众是该行业的各类相关人员,包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
  • 相关人员可以透过各种用于分析全球血脂检查市场的策略矩阵轻鬆做出决策。

目录

第一章 研究目标与前提条件

  • 调查目的
  • 先决条件
  • 简称

第二章 市场范围

  • 报告概述
    • 市场定义和范围
  • 执行摘要

第三章 市场动态、监理及趋势分析

  • 市场动态
  • 司机
  • 抑制因素
  • 机会
  • 影响分析
  • 重大进展
  • 法规环境
  • 产品上市及核准
  • PEST分析
  • 波特分析
  • 併购趋势
  • 产业趋势

4. 2020-2032年全球血脂检查市场(依检测类型划分)

  • 标准血脂谱
  • 进阶脂质检测

5. 2020-2032年全球血脂检查市场(依产品类型划分)

  • 装置
  • 试剂和试剂盒

6. 2020-2032年全球血脂检查市场(依应用领域划分)

  • 高血脂症
  • 高三酸甘油脂血症
  • 遗传性高胆固醇症
  • 低载脂蛋白血症
  • 坦齐尔氏症
  • 动脉粥状硬化
  • 其他血脂异常症

7. 2020-2032年全球血脂检查市场(依配方类型划分)

  • 处方笺测试
  • 非处方药 (OTC) 检测

8. 2020-2032年全球血脂检查市场(依最终用户划分)

  • 医院
  • 专科诊所
  • 病理检查室
  • 诊断诊所
  • 门诊手术中心
  • 居家医疗机构
  • 学术和研究机构

9. 2020-2032年全球血脂检查市场(按地区划分)

  • 北美洲
    • 美国
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲国家
  • 欧洲
    • 德国
    • 英国
    • 西班牙
    • 法国
    • 义大利
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • ASEAN
    • 亚太其他地区
  • 中东
    • 海湾合作委员会国家
    • 以色列
    • 其他中东国家
  • 非洲
    • 南非
    • 北非
    • 中非

第十章 竞争格局

  • Abbott Laboratories
  • Beckman Coulter Inc.
  • Hoffmann-La Roche Ltd.
  • Randox Laboratories Ltd.
  • Thermo Fisher Scientific Inc.
  • Siemens Healthcare GmbH
  • Bio-Rad Laboratories Inc.
  • Nova Biomedical Corporation
  • SD Biosensor, Inc.
  • PTS Diagnostics
  • Horiba Medical
  • Elitech Group
  • Menarini Group
  • VivaChek Biotech(Hangzhou)Co., Ltd.
  • Mico Bio Med

第十一章 分析师建议

  • 机会
  • 分析师观点
  • Coherent Opportunity Map

第十二章 参考文献与调查方法

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI8860

Lipid Panel Test Market is estimated to be valued at USD 11.82 Bn in 2025 and is expected to reach USD 20.13 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 11.82 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.90% 2032 Value Projection: USD 20.13 Bn

The global lipid panel test market represents a critical segment of the clinical diagnostics industry, encompassing comprehensive blood tests that measure various cholesterol and triglyceride levels to assess cardiovascular disease risk. Lipid panel tests, also known as lipid profiles or lipograms, evaluate total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides in patients' blood samples.

These diagnostic assessments serve as fundamental screening tools for healthcare providers to identify individuals at risk of developing atherosclerosis, coronary artery disease, and other cardiovascular complications. The market encompasses various testing methodologies including enzymatic assays, homogeneous assays, and advanced automated analyzers deployed across hospitals, diagnostic laboratories, and point-of-care settings.

With the increasing prevalence of lifestyle-related diseases, aging populations, and growing awareness of preventive healthcare measures, the demand for lipid panel testing continues to expand globally. The integration of technological advancements such as high-throughput analyzers, portable testing devices, and digital health platforms has revolutionized the accessibility and efficiency of lipid testing procedures, making them more convenient for both healthcare providers and patients across diverse healthcare settings worldwide.

Market Dynamics

The global lipid panel test market is primarily driven by the escalating prevalence of cardiovascular diseases, diabetes, and obesity worldwide, creating substantial demand for regular lipid monitoring and screening procedures. The aging global population, particularly in developed countries, significantly contributes to market growth as elderly individuals require frequent cardiovascular risk assessments and lipid profile monitoring.

Technological advancements in diagnostic equipment, including the development of high-throughput automated analyzers, point-of-care testing devices, and portable lipid testing solutions, enhance testing accuracy, efficiency, and accessibility, thereby driving market expansion. Government initiatives promoting preventive healthcare measures, cardiovascular disease screening programs, and healthcare awareness campaigns further stimulate market demand.

However, the market faces certain restraints including high costs associated with advanced diagnostic equipment and testing procedures, which may limit accessibility in resource-constrained healthcare settings and developing regions. Stringent regulatory requirements for diagnostic device approvals, quality control standards, and laboratory certifications create barriers to market entry and increase compliance costs for manufacturers. Limited healthcare infrastructure, shortage of skilled laboratory professionals, and inadequate reimbursement policies in certain regions also hinder market growth.

Nevertheless, significant opportunities exist in emerging markets with expanding healthcare infrastructure, increasing healthcare expenditure, and growing awareness about cardiovascular health. The integration of artificial intelligence, machine learning algorithms, and telemedicine platforms presents opportunities for developing innovative lipid testing solutions and remote monitoring capabilities. The rising trend of home-based healthcare and self-monitoring devices creates potential for consumer-friendly lipid testing products, while partnerships between diagnostic companies and healthcare providers can facilitate market penetration and service expansion globally.

Key Features of the Study

  • This report provides in-depth analysis of the global lipid panel test market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global lipid panel test market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Abbott Laboratories, Beckman Coulter Inc., F. Hoffmann-La Roche Ltd., Randox Laboratories Ltd., Thermo Fisher Scientific Inc., Siemens Healthcare GmbH, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, SD Biosensor, Inc., PTS Diagnostics, Horiba Medical, Elitech Group, Menarini Group, VivaChek Biotech (Hangzhou) Co., Ltd., and Mico Bio Med.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global lipid panel test market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lipid panel test market

Market Segmentation

  • Test Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Standard Lipid Profile
    • Total Cholesterol
    • Triglycerides
    • Low-Density Lipoprotein (LDL) Cholesterol
    • High-Density Lipoprotein (HDL) Cholesterol
    • Advanced Lipid Testing
    • LDL Particle Number (LDL-P)
    • Apolipoprotein B (ApoB)
    • Lipoprotein(a) (Lp(a))
    • Others (HDL Subclasses, VLDL Cholesterol etc.)
  • Product Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Devices
    • Automated Analyzers
    • Point-of-Care Testing Devices
    • Spectrophotometers
    • Others
    • Reagents and Kits
    • Cholesterol Test Kits
    • HDL and LDL Kits
    • Triglyceride Test Kits
    • Test Strips
    • Other Product Types
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Hyperlipidemia
    • Hypertriglyceridemia
    • Familial Hypercholesterolemia
    • Hypo Lipoproteinemia
    • Tangier Disease
    • Atherosclerosis
    • Other Lipid Disorders
  • Prescription Mode Insights (Revenue, USD Bn, 2020 - 2032)
    • Prescription-Based Testing
    • Over-the-Counter (OTC) Testing
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospitals
    • Specialty Clinics
    • Pathology Laboratories
    • Diagnostic Clinics
    • Ambulatory Surgical Centers
    • Home Care Settings
    • Academic and Research Institutes
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Abbott Laboratories
    • Beckman Coulter Inc.
    • Hoffmann-La Roche Ltd.
    • Randox Laboratories Ltd.
    • Thermo Fisher Scientific Inc.
    • Siemens Healthcare GmbH
    • Bio-Rad Laboratories Inc.
    • Nova Biomedical Corporation
    • SD Biosensor, Inc.
    • PTS Diagnostics
    • Horiba Medical
    • Elitech Group
    • Menarini Group
    • VivaChek Biotech (Hangzhou) Co., Ltd.
    • Mico Bio Med

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Lipid Panel Test Market, By Test Type
    • Global Lipid Panel Test Market, By Product Type
    • Global Lipid Panel Test Market, By Application
    • Global Lipid Panel Test Market, By Prescription Mode
    • Global Lipid Panel Test Market, By End User
    • Global Lipid Panel Test Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Lipid Panel Test Market, By Test Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Standard Lipid Profile
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • Total Cholesterol
      • Triglycerides
      • Low-Density Lipoprotein (LDL) Cholesterol
      • High-Density Lipoprotein (HDL) Cholesterol
  • Advanced Lipid Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • LDL Particle Number (LDL-P)
      • Apolipoprotein B (ApoB)
      • Lipoprotein(a) (Lp(a))
      • Others (HDL Subclasses, VLDL Cholesterol etc.)

5. Global Lipid Panel Test Market, By Product Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • Automated Analyzers
      • Point-of-Care Testing Devices
      • Spectrophotometers
      • Others
  • Reagents and Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • Cholesterol Test Kits
      • HDL and LDL Kits
      • Triglyceride Test Kits
      • Test Strips
      • Other Product Types

6. Global Lipid Panel Test Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hyperlipidemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Hypertriglyceridemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Familial Hypercholesterolemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Hypo Lipoproteinemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Tangier Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Atherosclerosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Other Lipid Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Lipid Panel Test Market, By Prescription Mode, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Prescription-Based Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Over-the-Counter (OTC) Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Lipid Panel Test Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pathology Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Diagnostic Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Home Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Lipid Panel Test Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Test Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Prescription Mode, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Test Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Prescription Mode, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Test Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Prescription Mode, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Test Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Prescription Mode, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Test Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Prescription Mode, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Test Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Prescription Mode, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Beckman Coulter Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hoffmann-La Roche Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Randox Laboratories Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthcare GmbH
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bio-Rad Laboratories Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nova Biomedical Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • SD Biosensor, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PTS Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Horiba Medical
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Elitech Group
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Menarini Group
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • VivaChek Biotech (Hangzhou) Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mico Bio Med
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us